NCT06248905

Brief Summary

The aim of this randomized controlled study is to investigate if the sequential administration of focused shock wave therapy and of a rehabilitation program based on the strengthening of gluteal muscles is more effective than a standard shock wave treatment for greater trochanteric pain syndrome

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
9mo left

Started Jan 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress76%
Jan 2024Feb 2027

Study Start

First participant enrolled

January 26, 2024

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

January 31, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 8, 2024

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2026

Expected
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2027

Last Updated

February 8, 2024

Status Verified

January 1, 2024

Enrollment Period

2.4 years

First QC Date

January 31, 2024

Last Update Submit

January 31, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • NRS Pain

    Change in lateral hip pain measured by the Numeric Rating Scale (NRS)

    6 months

Secondary Outcomes (3)

  • EQ5D Quality of life

    12 months

  • VISA-G Disability

    12 months

  • Functional capacity (strength of gluteal muscles)

    12 months

Study Arms (2)

exercise plus shockwaves

EXPERIMENTAL

Enrolled subject will be treated with focused shock wave therapy, once a week for three consecutive weeks, by a specialized physician, using a device powered by an electromagnetic generator. Focusing: (out-of-line) ultrasound-guided with the patient lying in lateral decubitus. Dosimetry: 1500-1800 shots per session with an energy flux density equal to 0.10-0.20 mJ/mm2 (frequency=4Hz). The experimental group will then start a physiotherapy program for the following 8 weeks. The program is made up of strengthening and stretching exercises of gluteal muscles, planned to be daily performed at home. Four supervised physiotherapy session will be planned on week 0-1-2-4, during which the exercise loading will be implemented.

Other: Rehabilitation program based on the strengthening of gluteal musclesOther: Extracorporeal shock wave therapy

shockwaves

ACTIVE COMPARATOR

Enrolled subject will be treated with focused shock wave therapy, once a week for three consecutive weeks, by a specialized physician, using a device powered by an electromagnetic generator. Focusing: (out-of-line) ultrasound-guided with the patient lying in lateral decubitus. Dosimetry: 1500-1800 shots per session with an energy flux density equal to 0.10-0.20 mJ/mm2 (frequency=4Hz).

Other: Extracorporeal shock wave therapy

Interventions

Physiotherapy program (8 weeks)

exercise plus shockwaves

Focused shock wave therapy (3 weeks)

exercise plus shockwavesshockwaves

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Unilateral hip pain of four weeks or longer duration
  • Pain to palpation in the greater trochanteric area at physical examination
  • Pain in hip end-range abduction/rotation/adduction at physical examination
  • Gluteal tendinopathy, in absence of full thickness tears at a sonographic examination of the gluteal tendons
  • Adult age and written informed consent

You may not qualify if:

  • No hip osteoarthritis, diagnosed according to Altman's criteria
  • No history of knee osteoarthritis
  • No history of rheumatologic diseases
  • No previous fractures or surgery in the affected limb
  • No clinical signs of lumbar radiculopathy at physical examination
  • No corticosteroid injections, since the onset of the current pain episode
  • No general contraindication to shock wave therapy (pregnancy, bleeding disorders or anticoagulant drug usage, cancer in the focal area)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fondazione IRCCS Policlinico San Matteo

Pavia, 27100, Italy

Location

MeSH Terms

Interventions

Extracorporeal Shockwave Therapy

Intervention Hierarchy (Ancestors)

Ultrasonic TherapyDiathermyHyperthermia, InducedTherapeuticsPhysical Therapy ModalitiesRehabilitation

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medicine Doctor

Study Record Dates

First Submitted

January 31, 2024

First Posted

February 8, 2024

Study Start

January 26, 2024

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

February 1, 2027

Last Updated

February 8, 2024

Record last verified: 2024-01

Locations